交易中 08-06 10:21:34 美东时间
+0.003
+1.04%
ProPhase Labs, Inc. will hold a Special Meeting of Shareholders on August 29, 2025, to vote on a proposal to increase authorized shares to 1 billion, aiming to attract high-value crypto treasury transactions and industry-leading participants. The company also focuses on collecting $50 million from Covid accounts receivables and advancing its BE-Smart esophageal cancer test, while exploring strategic alternatives for Nebula Genomics. This move is ...
07-29 12:00
Prophase Labs ( ($PRPH) ) has provided an announcement. On July 22, 2025, ProPh...
07-28 20:48
ProPhase Labs, Inc. has closed a $3 million private placement financing with senior secured convertible notes and warrants to support working capital, debt repayment, and crypto strategies. The notes, with a 20% original issue discount, are not convertible for the first four months. Proceeds will also aid in pursuing liquidity events like collecting Covid accounts receivable and selling Nebula Genomics. The company aims to explore a reverse merge...
07-23 12:00
ProPhase Labs shares are trading higher after the board authorized management t...
07-21 20:02
Shares of ENDRA Life Sciences Inc. (NASDAQ:NDRA) rose sharply in pre-market tra...
07-08 18:15
Prophase Labs ( ($PRPH) ) has provided an announcement. On June 22, 2025, ProPh...
06-27 05:51
ProPhase Labs Inc. (NASDAQ:PRPH), (the "Company" or "ProPhase") a next generation biotech, genomics and consumer products company, today announced that it has received an extension of 180 calendar days (the "Extension
06-26 19:34
ProPhase Labs Inc. received a 180-day extension from Nasdaq to regain compliance with the $1.00 bid price requirement, following the initial 180-day period expiring on June 24, 2025. The company must meet the bid price requirement by December 22, 2025, or face delisting. ProPhase continues to explore options to achieve compliance while maintaining operations and reporting obligations.
06-26 11:30
The latest announcement is out from Prophase Labs ( ($PRPH) ). On June 20, 2025...
06-26 05:31
Gainers Acurx Pharmaceuticals (NASDAQ:ACXP) stock moved upwards by 235.5% to $...
06-17 20:08